ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: SA-PO1117

Monocyte to High-Density Lipoprotein Cholesterol Ratio (MHR) and Carotid Intima-Media Thickness (cIMT) in Patients with CKD: Secondary Analysis of Pooled Clinical Study Data

Session Information

Category: CKD (Non-Dialysis)

  • 2301 CKD (Non-Dialysis): Epidemiology, Risk Factors, and Prevention

Authors

  • Oh, Ester, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
  • You, Zhiying, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
  • Jovanovich, Anna, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
  • Nowak, Kristen L., University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
Background

Monocyte to high-density lipoprotein cholesterol ratio (MHR) is an emerging prognostic marker of cardiovascular diseases, including atherosclerosis. Circulating monocytes contribute to plaque development, whereas, high-density lipoprotein (HDL) cholesterol neutralizes the pro-inflammatory and pro-oxidative properties of monocytes, resulting in an atheroprotective effect. Indeed, in the general population, MHR is associated with carotid intima-media thickness (cIMT; a measure of subclinical atherosclerosis). However, this association has not been assessed in a cohort with chronic kidney disease (CKD), a population with atherosclerotic risk. The current study aimed to examine whether MHR is associated with cIMT in patients with stage 3-4 CKD.

Methods

This pooled analysis included baseline data from four clinical studies (2 published [PMID: 27647856; 36636757] and 2 unpublished [NCT Number: NCT04911491; NCT05471518]) that measured monocyte number, serum HDL cholesterol levels, and cIMT in patients with stage 3-4 CKD. Univariate and multivariate regression models were used to evaluate associations of MHR with cIMT and to further adjust for clinically relevant covariates.

Results

A total of 59 participants (39% female; 76% white; mean±SD age 65±10 years; eGFR 41±13 mL/min/1.73m2; MHR 14±7; cIMT 0.73±0.26 mm) were included. There was an association between MHR and cIMT (β=0.286; P=0.03) in the unadjusted model (Figure). The association between MHR and cIMT was slightly attenuated after fully adjusting for age, sex, body mass index, and low-density lipoprotein cholesterol (β=0.266; P=0.06).

Conclusion

MHR may be associated with cIMT in patients with CKD; this observation should be explored further in a larger cohort.

Scatter plot of the association between monocyte to high-density lipoprotein cholesterol ratio (MHR) and carotid intima-media thickness (cIMT)

Funding

  • NIDDK Support